Table 1.
Biomarkers That Have Been Proposed for Gastrointestinal Tumors
Colon Biomarkers | Esophagus Biomarkers | Pancreas Biomarkers | Stomach Biomarkers |
---|---|---|---|
FAP | Ki-67, P53, P16, COX-2, EGFR, | CA19-9, CEA, K-ras, | cagA, vacA, babA2, IL1 |
APC | EGF, TGF-α, β-catenin, | P53, P16, MIC-1, | gene, PGI, PGII, IgG |
HNPCC | E-cadherin, c-erb-b2, cyclin | cyclin D2, TSLC1, | H. pylori |
hMSH2, hMLH1, hPMS1, hPMS2, | D1 | SPARC | |
hMSH3, hMSH6 | LOH: 17p/P53, 9p/P16 | Mitochondrial DNA | |
Sporadic | Aneuploidy, tetraploidy, | mutation | |
Tumor suppressor: P53, DCC, APC | Y-chromosome loss | ||
Oncogenes: Myc, ras, src, erbB2, | |||
MMR genes |